Top

Osteoporosis International

Published in:

01-06-2021 | Bisphosphonate | Letter to the Editor

Osteoporosis medication after fracture in older adults: an administrative data analysis

Authors: Y. Yamamoto, T. Chiba, S. Dohmae, K. Higashi, A. Nakazawa

Published in: Osteoporosis International | Issue 6/2021

Excerpt

Dear Editor, …

Miller PD (2016) Underdiagnoses and undertreatment of osteoporosis: the battle to be won. J Clin Endocrinol Metab 101:852–859. https://doi.org/10.1210/jc.2015-3156CrossRefPubMed

International Osteoporosis Foundation (N.D.) Broken bones, broken lives: a roadmap to solve the fragility fracture crisis in Europe. https://www.osteoporosis.foundation/what-we-do/science-and-research/latest-projects%2D%2Dbroken-bones-broken-lives Accessed 30 March 2021

Greenspan SL, Wyman A, Hooven FH, Adami S, Gehlbach S, Anderson FA Jr, Boone S, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Silverman S, Siris ES, Watts NB (2012) Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women. J Am Geriatr Soc 60:455–461. https://doi.org/10.1111/j.1532-5415.2011.03854.xCrossRefPubMedPubMedCentral

Akesson K, Marsh D, Mitchell PJ, AR ML, Stenmark J, Pierroz DD, Kyer C, Cooper C, IOF Fracture Working Group (2013) Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int 24:2135–2152. https://doi.org/10.1007/s00198-013-2348-zCrossRefPubMedPubMedCentral

McClung M, Harris ST, Miller PD, Bauer DC, Davison KS, Dian L, Hanley DA, Kendler DL, Yuen CK, Lewiecki EM (2013) Bisphosphonate therapy for osteoporosis: benefits, risks, and drug holiday. Am J Med 126:13–20. https://doi.org/10.1016/j.amjmed.2012.06.023CrossRefPubMed

Sato M, Vietri J, Flynn JA, Fujiwara S (2014) Treatment for osteoporosis among women in Japan: associations with patient characteristics and patient-reported outcomes in the 2008–2011 Japan National Health and Wellness Surveys. J Osteoporos 2014:909153. https://doi.org/10.1155/2014/909153CrossRefPubMedPubMedCentral

Gu T, Lawrence DF, Stephenson JJ, Yu J (2016) Physicians’ perspectives on the treatment of osteoporosis patients with bisphosphonates. Clin Interv Aging 11:1–8. https://doi.org/10.2147/CIA.S97593CrossRefPubMedPubMedCentral

Hashimoto RE, Brodt ED, Skelly AC, Dettori JR (2014) Administrative database studies: goldmine or goose chase? Evid Based Spine Care J 5:74–76. https://doi.org/10.1055/s-0034-1390027CrossRefPubMedPubMedCentral

Title: Osteoporosis medication after fracture in older adults: an administrative data analysis
Authors: Y. Yamamoto
T. Chiba
S. Dohmae
K. Higashi
A. Nakazawa
Publication date: 01-06-2021
Publisher: Springer London
Keywords: Bisphosphonate
Osteoporosis
Osteoporosis
Denosumab
Selective Estrogen Receptor Modulator
Denosumab
Published in: Osteoporosis International / Issue 6/2021
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-021-05973-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Osteoporosis medication after fracture in older adults: an administrative data analysis

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2021

Zoledronic acid reduces the rate of clinical fractures after surgical repair of a hip fracture regardless of the Pretreatment bone mineral density

Use of fractal analysis in dental images for osteoporosis detection: a systematic review and meta-analysis

Peri-operative derangement in liver function tests in older patients with neck of femur fracture

Long-term direct and indirect economic burden associated with osteoporotic fracture in US postmenopausal women

Vitamin D and bone health status in beta thalassemia patients—systematic review

Association between type 1 diabetes mellitus and reduced bone mineral density in children: a meta-analysis